UnitedHealth (UNH) vs S&P 500
UnitedHealth closed at $350.82 on April 21, 2026, with a $276.23 billion market cap. SPY traded near $708 the same week.
Also known as: UnitedHealth (UNH) (STK_UNH, UnitedHealth) · S&P 500 ETF (SPY) (ETF_SPY, S&P 500, SPX, SP500)
Why This Comparison Matters
UnitedHealth closed at $350.82 on April 21, 2026, with a $276.23 billion market cap. SPY traded near $708 the same week. UNH represents approximately 0.7 percent of the S&P 500 and is the largest managed-care company in the US. The pair has been one of the most volatile single-stock-vs-index trades in equity markets through 2024-2026 due to UNH-specific stress (DOJ investigation, Change Healthcare cyber, Medicare Advantage margin compression). UNH lost approximately 30 percent peak-to-trough from October 2023 highs near $530 while SPY gained approximately 25 percent over the same period, producing a 55 percentage point UNH-vs-SPY underperformance. Year-to-date 2026, UNH has stabilized at +5 percent versus SPY +1 percent, indicating partial recovery.
UNH's Position in the S&P 500
UNH at $276.23 billion market cap represents approximately 0.7 percent of the S&P 500. Within healthcare (approximately 12 percent of S&P), UNH is the second-largest holding after Eli Lilly. The S&P 500 healthcare sector at 12 percent is the third-largest sector after technology (~30 percent) and financials (~13 percent).
The UNH/SPY ratio currently trades at approximately 0.495 (UNH $350.82 / SPY $708). The ratio peaked near 0.85 in October 2023 (UNH approaching $530, SPY at $590) and bottomed near 0.43 in mid-2024 during the Change Healthcare cyber and DOJ investigation announcement period. The current 0.495 reflects partial recovery as Q1 2026 results stabilized and management raised guidance.
The 2024-2025 Catastrophic Drawdown
UNH lost 30 percent peak-to-trough during 2024-2025 from $530 in October 2023. Three drivers compounded simultaneously, producing one of the largest single-stock drawdowns in S&P 500 history.
First, Change Healthcare cyber attack: February 2024 ransomware attack on UNH-owned Change Healthcare disrupted claims processing across the US healthcare system for weeks. The incident produced approximately $2 billion in remediation costs, Senate hearings, and significant reputation damage. UNH stock declined roughly 20 percent over the subsequent 8 weeks.
Second, Medicare Advantage margin compression: 2024 CMS reimbursement updates were less generous than expected, while medical-cost trends accelerated post-COVID. UnitedHealthcare margins compressed from 6 percent in 2023 to 5 percent in 2024 to approximately 4 percent in 2025. Combined with a 50 percent share-of-MA market position, the margin compression was material.
Third, DOJ investigation: announced 2024 into Medicare Advantage billing practices, focusing on diagnoses that increased federal payments. Senate Permanent Subcommittee on Investigations parallel inquiry accused UNH of "aggressively gaming" MA. The combined regulatory overhang remained throughout 2025.
Why UNH Failed as a Defensive in 2024-2025
Healthcare is supposed to be defensive. UNH historically traded as a quality-defensive name with stable cash flows, dividend growth, and lower volatility than SPY. The 2024-2025 episode broke this narrative because UNH faced simultaneous idiosyncratic stress that overwhelmed any defensive macro flow.
Conditional Forward Response (Tail Events)
How S&P 500 ETF (SPY) has historically behaved in the 5 sessions following a top-decile or bottom-decile daily move in UnitedHealth (UNH). Computed from 1,289 aligned daily observations ending .
Following these triggers, S&P 500 ETF (SPY) rises 0.12% on average over the next 5 sessions, versus an unconditional baseline of +0.24%. 129 qualifying events; S&P 500 ETF (SPY) closed positive in 58% of them.
90-Day Statistics
Explore Each Metric
Related Scenarios & Forecasts
Get daily macro analysis comparing key metrics delivered to your inbox. Stay ahead of market-moving divergences.
Frequently Asked Questions
What is UNH's position in the S&P 500?+
UNH at $276.23 billion market cap represents approximately 0.7 percent of the S&P 500. Within healthcare (~12 percent of S&P), UNH is the second-largest holding after Eli Lilly. The S&P 500 healthcare sector at 12 percent is the third-largest sector after technology (~30 percent) and financials (~13 percent). The UNH/SPY ratio is approximately 0.495 (UNH $350.82 / SPY $708), with 12-month range 0.43-0.55 and 5-year range 0.43-0.85. The ratio peaked at 0.85 in October 2023 and bottomed at 0.43 in mid-2024.
How big was the 2024-2025 UNH drawdown?+
UNH lost 30 percent peak-to-trough from October 2023 highs near $530 to mid-2024 lows. SPY gained approximately 25 percent over the same period, producing a 55 percentage point UNH-vs-SPY underperformance. Three drivers compounded: Change Healthcare February 2024 ransomware attack ($2 billion remediation, ~20 percent stock decline over 8 weeks), Medicare Advantage margin compression (UnitedHealthcare margins from 6% in 2023 to ~4% in 2025), DOJ investigation announced 2024 into MA billing practices plus Senate Permanent Subcommittee parallel inquiry accusing UNH of aggressively gaming MA reimbursement.
Is UNH still defensive after 2024-2025?+
The 2024-2025 episode broke the defensive narrative. Healthcare is supposed to be defensive: UNH historically traded as a quality-defensive name with stable cash flows. UNH 2008-2009 recession: +5 percent vs SPY -56 percent (61pp outperformance). UNH 2020 COVID: +12 percent vs SPY -34 percent (46pp outperformance). The 2024-2025 stress overwhelmed defensive characteristics because UNH faced simultaneous idiosyncratic stress (cyber, DOJ, MA margins). The defensive thesis remains untested in a recessionary scenario in the post-Change-cyber era. For any 2026 recession, historical 60pp recession outperformance may compress to 20-30pp if regulatory overhangs persist.
Related Comparisons
Explore Across Convex
Data sourced from FRED, CoinGecko, CBOE, and other providers. This page is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results.